Integrin beta-like 1 mediates fibroblast–cardiomyocyte crosstalk to promote cardiac fibrosis and hypertrophy
Cardiovascular Research · 19.08.2023 · 119 (10) · 1928-1941
DOI: 10.1093/cvr/cvad104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 03.07.2023. Verfasst von XiaoQiang Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Heart Failure. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Medicine and Engineering Cross, Shanghai Jiaotong University.
Abstract (Originalsprache)
Aims
Crosstalk between fibroblasts and cardiomyocytes (CMs) plays a critical role in cardiac remodelling during heart failure (HF); however, the underlying molecular mechanisms remain obscure. Recently, a secretory protein, Integrin beta-like 1 (ITGBL1) was revealed to have detrimental effects on several diseases, such as tumours, pulmonary fibrosis, and hepatic fibrosis; whereas the effect of ITGBL1 on HF is unclear. The purpose of this study was to evaluate its contribution to volume overload-induced remodelling. Methods and results In this study, we identified ITGBL1 was highly expressed in varied heart diseases and validated in our TAC mice model, especially in fibroblasts. To investigate the role of ITGBL1 in in vitro cell experiments, neonatal rat fibroblasts (NRCFs) and cardiomyocytes (NRCMs) were performed for further study. We found that in comparison to NRCMs, NRCFs expressed high levels of ITGBL1. Meanwhile, ITGBL1 was upregulated in NRCFs, but not in NRCMs following angiotensin-II (AngII) or phenylephrine stimulation. Furthermore, ITGBL1 overexpression promoted NRCFs activation, whereas knockdown of ITGBL1 alleviated NRCFs activation under AngII treatment. Moreover, NRCFs-secreted ITGBL1 could induce NRCMs hypertrophy. Mechanically, ITGBL1-NME/NM23 nucleoside diphosphate kinase 1 (NME1)-TGF-β-Smad2/3 and Wnt signalling pathways were identified to mediate NRCFs activation and NRCMs hypertrophy, respectively. Finally, the knockdown of ITGBL1 in mice subjected to transverse aortic constriction (TAC) surgery recapitulated the in vitro findings, demonstrating blunted cardiac fibrosis, hypertrophy, and improved cardiac function.
Conclusions
ITGBL1 is an important functional mediator between fibroblast–cardiomyocyte crosstalk and could be an effective target for cardiac remodelling in HF patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: SongWen Chen, ShaoWen Liu, LiDong Cai
Förderung
- National Natural Science Foundation of China
- Medicine and Engineering Cross
- Shanghai Jiaotong University
Zitieren
APA
Chen, X., Li, X., Wu, X., Ding, Y., Li, Y., Zhou, G., Wei, Y., Chen, S., Lu, X., Xu, J., Liu, S., Li, J., & Cai, L. (2023). Integrin beta-like 1 mediates fibroblast–cardiomyocyte crosstalk to promote cardiac fibrosis and hypertrophy. Cardiovascular Research, 119(10), 1928-1941. https://doi.org/10.1093/cvr/cvad104
Vancouver
Chen X, Li X, Wu X, Ding Y, Li Y, Zhou G, et al. Integrin beta-like 1 mediates fibroblast–cardiomyocyte crosstalk to promote cardiac fibrosis and hypertrophy. Cardiovascular Research. 2023;119(10):1928-1941. doi:10.1093/cvr/cvad104
BibTeX
@article{Chen2023,
author = {Chen, XiaoQiang and Li, XinTao and Wu, XiaoYu and Ding, Yu and Li, Ya and Zhou, GenQing and Wei, Yong and Chen, SongWen and Lu, XiaoFeng and Xu, Juan and Liu, ShaoWen and Li, Jun and Cai, LiDong},
title = {Integrin beta-like 1 mediates fibroblast–cardiomyocyte crosstalk to promote cardiac fibrosis and hypertrophy},
journal = {Cardiovascular Research},
year = {2023},
volume = {119},
number = {10},
pages = {1928--1941},
doi = {10.1093/cvr/cvad104}
}
EUVIMED